Substra

Fuel new breakthroughs in oncology with spatial omics

Building the largest spatial omics dataset in oncology
Book a demo

Apply AI to large-scale spatial omics to discover:

New therapeutic targets
New patient subgroups
New diagnostic and prognostic biomarkers
New treatment response and resistance mechanisms

Pioneering large-scale spatial omics with world-leading academic and industry partners

7
Cancer indications
NSCLC, Ovarian, Bladder, Mesothelioma, Glioblastoma, Breast Cancer, DLBCL
6
Data modalities
Spatial transcriptomics, Single-cell RNA-seq, Bulk RNA-seq, Clinical data, WES, H&E
5
Academic partners
Gustave Roussy, University of Pittsburgh, Uniklinikum Erlangen, Charitè, CHUV
Play

MOSAIC + Owkin

Follow the MOSAIC journey

As we combine spatial omics with AI to decode complex biology and ensure every patient gets the right treatment.

MOSAIC website

Why work with Owkin to leverage spatial omics data?

Largest spatial omics dataset in oncology
  • First initiative of its kind
  • 100x bigger than existing datasets
Exceptional level of data depth
  • 6 data modalities
  • 7 cancer indications
  • Multiscale understanding of biology
AI-ready dataset
  • Centralized data with controlled architecture
  • Data harmonization for ML
  • Expertly curated
World-leading partners
  • Top cancer research hospitals
  • Cutting-edge spatial omic stechnologies
Owkin’s expertise
  • Scientific expertise
  • AI/ML expertise
  • Consortia expertise
Unique benefits
  • Deep insights into a novel dataset
  • Work with spatial omics data
Substra

Book a demo with Owkin